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OBJECTIVES We investigated the gene expression of calcium-handling genes including L-type calcium
channel, sarcoplasmic reticular calcium adenosine triphosphatase (Ca21-ATPase), ryanodine
receptor, calsequestrin and phospholamban in human atrial fibrillation.
BACKGROUND Recent studies have demonstrated that atrial electrical remodeling in atrial fibrillation is
associated with intracellular calcium overload. However, the changes of calcium-handling
proteins remain unclear.
METHODS A total of 34 patients undergoing open heart surgery were included. Atrial tissue was obtained
from the right atrial free wall, right atrial appendage, left atrial free wall and left atrial
appendage, respectively. The messenger ribonucleic acid (mRNA) amount of the genes was
measured by reverse transcription–polymerase chain reaction and normalized to the mRNA
levels of glyceraldehyde 3-phosphate dehydrogenase.
RESULTS The mRNA of L-type calcium channel and of Ca21-ATPase was significantly decreased in
patients with persistent atrial fibrillation for more than 3 months (0.36 6 0.26 vs. 0.90 6 0.88
for L-type calcium channel; 0.69 6 0.42 vs. 1.21 6 0.68 for Ca21-ATPase; both p , 0.05,
all data in arbitrary unit). We further demonstrated that there was no spatial dispersion of the
gene expression among the four atrial tissue sampling sites. Age, gender and underlying
cardiac disease had no significant effects on the gene expression. In contrast, the mRNA levels
of ryanodine receptor, calsequestrin and phospholamban showed no significant change in
atrial fibrillation.
CONCLUSIONS L-type calcium channel and the sarcoplasmic reticular Ca21-ATPase gene were down-
regulated in atrial fibrillation. These changes may be a consequence of, as well as a
contributory factor for, atrial fibrillation. (J Am Coll Cardiol 1999;33:1231–7) © 1999 by the
American College of Cardiology
Atrial fibrillation is the most common tachyarrhythmia in
humans. It causes palpitations, decreased cardiac output,
heart failure and systemic thromboembolism, and is associ-
ated with a significant morbidity and mortality (1–3).
Current treatment modalities for atrial fibrillation are far
from satisfactory. Despite aggressive treatment, the recur-
rence rate of atrial fibrillation is still high, and many patients
finally develop chronic persistent atrial fibrillation refractory
to any treatment including electrical cardioversion. There is
evidence showing that atrial fibrillation begets atrial fibril-
lation, and through this vicious cycle atrial fibrillation
becomes incessant (4). This phenomenon was thought to be
due to atrial electrical remodeling, which results in progres-
sive shortening of the atrial refractory period after rapid
atrial depolarization (5–7). This is an important contribut-
ing factor for the maintenance of atrial fibrillation.
The underlying mechanism of atrial electrophysiologic
remodeling remains unknown and has been the focus of
From the *Pharmacological Institute, College of Medicine, National Taiwan
University, †Department of Internal Medicine and ‡Department of Surgery, National
Taiwan University Hospital, Taipei, Taiwan. This study was supported in part by the
National Taiwan University Hospital Research Grant NTUH 88S1003.
Manuscript received July 7, 1998; revised manuscript received November 18, 1998,
accepted December 24, 1998.
Journal of the American College of Cardiology Vol. 33, No. 5, 1999
© 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00
Published by Elsevier Science Inc. PII S0735-1097(99)00008-X
many studies (5–11). There has been evidence showing that
intracellular calcium overload plays an important role in
atrial electrical remodeling. Morillo and coworkers investi-
gated the mechanism of atrial remodeling using a rapid
atrial pacing canine model (8). They showed that the atrial
effective refractory period shortened after artificial pacing,
and the atrial tissue showed sarcoplasmic reticulum disrup-
tion and mitochondria swelling under electron microscope
after rapid atrial pacing for 6 weeks. Similar findings have
been reported by Ausma et al. in goats (9). These findings
are suggestive of intracellular calcium overload. Subsequent
studies further proved the effectiveness of L-type calcium
channel blocking agents in preventing electrical remodeling
and mitochondria swelling in a rapid atrial pacing canine
model (11–13).
All the above studies showed the important role of
calcium homeostasis in atrial electrical remodeling. The
cytosolic calcium homeostasis in myocytes involves the
influx of extracellular calcium through L-type calcium
channels and the release, uptake and storage of the sarco-
plasmic reticulum calcium store. Therefore, we propose to
investigate the gene expression changes of these calcium-
handling proteins in atrial tissue from patients with atrial
fibrillation. These proteins include L-type calcium channel,
ryanodine receptor, calcium adenosine triphosphatase
(Ca21-ATPase), calsequestrin and phospholamban.
METHODS
Patients. A total of 34 patients undergoing open heart
surgery were included. There were 15 men and 19 women
with a mean age of 55 6 14 years (range 17 to 77). Atrial
fibrillation was present in 26 of the patients and absent in
eight. The underlying heart disease was rheumatic heart
disease in 23 and nonrheumatic heart disease in the remain-
ing 11. The clinical characteristics are shown in Table 1. A
piece of atrial tissue of 0.1 to 0.5 g was obtained during the
surgery from the right atrial appendage, the right atrial free
wall, the left atrial appendage and the left atrial free wall,
respectively. Since a left atrial tissue sampling was necessary,
only surgical procedures involving a left atriotomy were
included.
Clinical parameters. The onset and duration of atrial
fibrillation were obtained by history taking and serial elec-
trocardiograms. We scored atrial fibrillation by the follow-
ing system: 0 5 no atrial fibrillation, 1 5 paroxysmal atrial
fibrillation, 2 5 persistent atrial fibrillation for less than 3
months, 3 5 persistent atrial fibrillation for more than 3
months. The right atrial pressure and pulmonary wedge
pressure were recorded during cardiac catheterization and
represented the right and left atrial filling pressure, respec-
tively. Use of calcium channel blockers was defined as
long-term use of verapamil for the control of ventricular rate
in atrial fibrillation.
Ribonucleic acid extraction and reverse transcription.
Total cellular ribonucleic acid (RNA) extraction was per-
formed immediately after obtaining the atrial tissue. The
tissue was homogenized with a Polytrone-Aggregate (Dis-
pergier und Mischtechnik, Littau, Switzerland), and Trizol
solution (Gibco BRL, Grand Island, New York) was added
for RNA extraction. The extracted RNA was dissolved in
diethyl pyrocarbonate–treated distilled water. Spectropho-
tometry at 260 and 280 nm was performed to measure the
amount and quality of RNA. The RNA was then converted
to complementary deoxyribonucleic acid (cDNA) by reverse
transcription with random hexanucleotides and avian my-
oloblastosis virus reverse transcriptase (Boehringer, Mann-
heim, Germany).
Polymerase chain reaction. Table 2 shows the DNA
sequence for all the primers used in the study. All the primer
pairs for calcium-handling genes were designed according to
the human cardiac DNA sequence (14–18). The L-type
calcium channel primer pair was designed to amplify the
alpha subunit of the channel, and all the alternatively spliced
messenger RNA (mRNA) was amplified to yield a single
DNA band on agarose gel electrophoresis. The primer pairs
were specific to their target genes, and a similarity search in
the GenBank revealed no false priming to noncardiac
isoforms of the calcium-handling genes or to any known
human gene sequence. The polymerase chain reaction
condition was 95°C for 5 s, 55°C for 30 s and 72°C for 60 s
with a final extension time of 5 min at 72°C. The glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) gene was
used as the housekeeping gene. For each of the genes of
interest, cDNA from all patients underwent polymerase
chain reaction at the same time. The primers of GAPDH
were added for coamplification in all reactions (19). The
reaction products were analyzed by agarose gel electro-
phoresis. Optic densitometry was performed after the gel
was stained with ethidium bromide for measuring the DNA
amount. Differing amounts of a standard DNA sample (0.2
mg/ml) was loaded on all gels, and a linear regression curve
between the OD number and the known DNA amount was
obtained.
Statistical analysis. The mRNA amount of the gene was
correlated with atrial fibrillation score, sampling sites, age,
gender, right atrial pressure, pulmonary wedge pressure, use
of calcium channel blockers and underlying cardiac disease.
Linear regression was used for correlation between the
mRNA amount and atrial fibrillation score, age, right atrial
Abbreviations and Acronyms
Ca21-ATPase 5 calcium adenosine triphosphatase
cDNA 5 complementary deoxyribonucleic acid
GAPDH 5 glyceraldehyde 3-phosphate
dehydrogenase
ICa 5 ionized calcium
mRNA 5 messenger ribonucleic acid
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pressure and pulmonary wedge pressure. Student t test was
used for comparing the mRNA amount and gender, atrial
fibrillation (less than three months or more than three
months), use of calcium channel blockers and underlying
cardiac disease (rheumatic or nonrheumatic). Analysis of
variance was used for comparing the mRNA amount from
four different sampling sites.
RESULTS
Validation of the polymerase chain reaction. Polymerase
chain reaction using each specific primer pair yielded only
one DNA band of predicted size. Coamplification of each of
the calcium-handling protein genes together with GAPDH
showed no interference between the primer pairs, and the
two DNA bands could be well separated by agarose gel
electrophoresis (Fig. 1). For measuring the DNA amount of
the polymerase chain reaction products, 0.01, 0.02, 0.04,
0.08, 0.12 and 0.16 mg of sample DNA was loaded on each
gel. Linear regression of the known DNA amount and the
OD number by ethidium bromide ultraviolet fluorescence
showed a good linear relationship (r2 . 0.95). The DNA
amount of all polymerase chain reaction bands was esti-
mated by the linear regression formula, and the mRNA
amount of the calcium-handling genes was normalized to
the mRNA amount of GAPDH.
Relationship between mRNA levels and atrial fibrilla-
tion. Table 3 shows the comparison of mRNA levels
between patients with persistent atrial fibrillation for more
than three months (score 3) and patients without persistent
atrial fibrillation for more than three months (score 0, 1 and
2). We found that the mRNA levels of L-type calcium
channel and levels of Ca21-ATPase were significantly
Table 1. Demographic and Clinical Characteristics of the Study Patients
Patient
No.
Gender/
Age (yr) Cardiac dz RAP PWP
Af
Score
CCB
Use Atrial Sampling Site
1 M/55 IE 1 17 0 2 LAA, RAA, RAF
2 M/55 RHD 7 23 3 2 LAA, RAA, RAF
3 M/41 MVP NA NA 0 2 LAA, RAA, RAF
4 M/64 AR 3 7 0 2 LAF, RAA, RAF
5 M/49 RHD 6 30 1 2 LAA, LAF, RAA, RAF
6 M/54 RHD 8 18 3 2 LAA, LAF, RAA, RAF
7 F/31 RHD 3 20 1 2 LAA, RAA, RAF
8 F/67 VSD, RCT 4 13 2 1 LAA, LAF, RAA, RAF
9 F/58 RHD 7 17 2 2 LAA, LAF, RAA, RAF
10 F/44 RHD 13 14 2 2 LAA, LAF, RAA, RAF
11 F/67 RHD 5 15 3 2 LAF, RAF
12 F/75 RHD 7 16 3 2 LAF, RAA, RAF
13 M/51 RHD 8 22 3 2 LAF, RAA, RAF
14 F/35 RHD 9 31 1 1 LAA, LAF, RAA, RAF
15 F/65 RHD NA NA 2 2 LAA, RAA, RAF
16 M/17 RHD 0 8 1 2 LAF, RAA, RAF
17 F/65 RCT 19 22 3 2 RAA
18 M/72 MVP 9 12 3 1 LAA, LAF, RAF
19 F/38 RHD NA NA 3 2 LAA, LAF, RAA, RAF
20 F/77 RHD 6 16 3 2 LAA, LAF, RAA, RAF
21 F/46 RHD 5 16 0 2 LAA, LAF, RAA, RAF
22 F/51 RHD 10 30 3 2 LAA, LAF, RAA, RAF
23 F/52 RHD 9 22 3 2 LAA, LAF, RAA, RAF
24 F/59 RHD 6 23 2 1 LAA, LAF, RAA, RAF
25 M/58 RCT 6 13 0 2 LAA, LAF, RAA, RAF
26 F/64 RHD 6 20 3 2 LAA, LAF, RAA, RAF
27 M/51 RHD NA NA 3 2 LAA, LAF, RAA, RAF
28 M/71 RHD 8 16 3 2 LAA, LAF, RAA, RAF
29 M/61 RHD 4 20 3 2 LAA, LAF, RAA, RAF
30 F/76 AR 6 30 0 2 RAA, RAF
31 F/47 RHD 7 25 1 2 LAA, LAF, RAA, RAF
32 M/61 MVP 5 19 0 2 LAA, LAF, RAA, RAF
33 F/50 RCT 4 7 3 1 LAA, LAF, RAA, RAF
34 M/36 MVP 5 15 0 2 LAA, LAF, RAA, RAF
Af 5 atrial fibrillation; AR 5 aortic regurgitation; CCB 5 calcium channel blockers; dz 5 disease; F 5 female; IE 5 infective endocarditis; LAA 5 left atrial appendage; LAF 5
left atrial free wall; M 5 male; MVP 5 mitral valve prolapse; NA 5 not available; PWP 5 pulmonary wedge pressure in mm Hg; RAA 5 right atrial appendage; RAF 5 right
atrial free wall; RAP 5 right atrial pressure in mm Hg; RCT 5 rupture of chordae tendineae; RHD 5 rheumatic heart disease; VSD 5 ventricular septal defect.
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reduced in patients with persistent atrial fibrillation for
more than three months. In contrast, the mRNA levels of
calsequestrin, ryanodine receptor and phospholamban
showed no significant change (Fig. 1). Figure 2 shows the
mRNA levels of the Ca21-ATPase and L-type calcium
channel in patients with different atrial fibrillation score.
The mRNA was significantly reduced in patients with atrial
fibrillation for .3 months, whereas the mRNA amount
among patients with atrial fibrillation 0, 1 and 2 was not
significantly different. This indicated that down-regulation
of Ca21-ATPase and L-type calcium channel was observed
only when the duration of atrial fibrillation was greater than
three months but was not observed in patients with parox-
ysmal atrial fibrillation or with atrial fibrillation of shorter
duration.
Dispersion of mRNA levels. The mRNA levels were
correlated with the sites of atrial tissue sampling. We found
that the mRNA levels were not significantly influenced by
the site of atrial tissue sampling. Figure 1 shows a repre-
sentative polymerase chain reaction result. Despite a large
variation of L-type calcium channel and Ca21-ATPase
mRNA levels between patients, the mRNA levels of the
genes were not significantly different among the four atrial
tissue sampling sites in the same patient. Therefore, we did
not find spatial dispersion of the gene expression among the
right atrial free wall, right atrial appendage, left atrial free
wall and left atrial appendage.
Analysis of other parameters. The influence of all clinical
parameters was analyzed. The results are summarized in
Table 4. We showed that gender, age, right atrial pressure,
pulmonary wedge pressure, the use of calcium channel
blocker and the underlying disease (analyzed as rheumatic
and nonrheumatic) had no significant effects on the expres-
Table 2. The Nucleotide Sequence of All Primers Used in the Study
Genes Primer Sequence Reference
L-type calcium channel
Sense primer 59-GTACAAGAACTGTGAGCTGG 14
Antisense primer 59-GATCACCGCGTAGATGAAGA 14
Ca21-ATPase
Sense primer 59-TTGCATTGCAGTCTGGATCA 17
Antisense primer 59-TCCAAAGCAGAGTCATTACA 17
Ryanodine receptor
Sense primer 59-AAGTGCCAGAGTCAGCATTC 15
Antisense primer 59-AGTAGTATCCAATGATGCAG 15
Calsequestrin
Sense primer 59-ATAGGCTTTGTGATGGTGGA 18
Antisense primer 59-GCAACAAGCAGAGGAAAGTC 18
Phospholamban
Sense primer 59-ACCTCTAGATCTGCAGCTTG 16
Antisense primer 59-GTTAGGCTGGAATGGAAGAC 16
GAPDH
Sense primer 59-TCCATGACAACTTTGGCATCGTGG 19
Antisense primer 59-GTTGCTGTTGAAGTCACAGGAGAC 19
Ca21-ATPase 5 calcium adenosine triphosphatase; GAPDH 5 glyceraldehyde 3-phosphate dehydrogenase.
Figure 1. Representative figures of the polymerase chain reaction
products after agarose gel electrophoresis. Coamplification of each
of the calcium-handling protein genes with glyceraldehyde
3-phosphate dehydrogenase (GAPDH) showed no interference
between the primer pairs, and the two deoxyribonucleic acid bands
could be well separated by gel electrophoresis (upper band for
calcium-handling protein and lower band for GAPDH). The
upper panel shows the polymerase chain reaction results from
Patient No. 13 and the lower panel from Patient No. 21, and the
samples for each calcium-handling gene were right atrial append-
age, right atrial free wall, left atrial appendage and left atrial free
wall from left to right. Despite a large variation of messenger
ribonucleic acid (mRNA) levels of L-type calcium channel and
calcium adenosine triphosphatase (Ca21-ATPase) between pa-
tients, the mRNA levels of the genes among the four atrial
sampling sites were not significantly different in the same patient.
Lane specification: lanes 1 and 22 5 molecular weight marker;
lanes 2 to 5 5 L-type calcium channel; lanes 6 to 9 5 Ca21-
ATPase; lanes 10 to 13 5 calsequestrin (CQ); lanes 14 to 17 5
ryanodine receptor (RYR); lanes 18 to 21 5 phospholamban (PLB).
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sion of the genes. We showed that atrial fibrillation was the
only factor that influenced the mRNA amount of L-type
calcium channel and Ca21-ATPase.
DISCUSSION
In this study, we found that the mRNA levels of L-type
calcium channel and sarcoplasmic reticular Ca21-ATPase
were down-regulated in human atrial fibrillation. We fur-
ther showed that these changes were independent of the
underlying cardiac disease, atrial filling pressure, gender, age
and use of calcium channel blockers. A decrease of mRNA
level was observed for L-type calcium channel and Ca21-
ATPase, whereas the mRNA levels for other genes such as
ryanodine receptor, calsequestrin, phospholamban and
GAPDH were not significantly altered. Therefore, these
changes cannot be attributed to a dilutional effect caused by
a decrease of atrial myocytes.
Comparison with previous studies in atrial electrical
remodeling. The shortening of the atrial refractory period
in response to rapid atrial depolarization has been demon-
strated in experimental animals as well as in human studies
(5–7). However, studies with regard to the underlying
mechanism and the associated cellular changes are mostly
done in goats or dogs. Mitochondria swelling and disrup-
tion of sarcoplasmic reticulum have been demonstrated in
dogs and goats with rapid atrial pacing (8,9,11), and these
findings are characteristic of intracellular calcium overload.
Yue et al. (20) further showed that ICa was decreased in the
same animal model and might be responsible for the
shortening of atrial refractory period. Van Wagoner et al.
(21) investigated the changes of outward potassium current
in atrial fibrillation. Although this study is exceptional in
being a human study, the results showed a paradoxical
decrease of outward potassium current, which should result
in a prolongation of action potential duration and atrial
refractory period (22).
All the above studies suggest that a decrease of ICa was
responsible for the shortening of the atrial refractory period
in atrial fibrillation. However, there are few reports that
make a direct measurement of atrial tissue ICa in human
atrial fibrillation. In the present study, we demonstrated that
the mRNA amount of L-type calcium channel is reduced in
atrial tissue from human subjects with atrial fibrillation.
This would result in a decrease of the number of L-type
calcium channels and therefore a decrease of ICa. Further-
more, a decrease of the mRNA of L-type calcium channel
would result in a decrease of channel number without a
change in channel properties. This finding is in agreement
with the observations by Yue et al. that ICa decreased after
rapid atrial pacing for 42 days in dogs and the decrease of
ICa was not associated with a change of the gating or kinetic
properties of the calcium channel (20).
The decrease of sarcoplasmic reticular Ca21-ATPase in
atrial fibrillation is reported here for the first time. Since the
Ca21-ATPase is responsible for calcium reuptake into the
sarcoplasmic reticulum, the decrease of Ca21-ATPase
should result in decreased reuptake and cytosolic calcium
overload, which is characteristic in atrial electrical remod-
eling as suggested by several previous reports (8–13).
Calcium overload and atrial electrical remodeling. Since
the most important electrophysiologic change of atrial cells
in response to rapid depolarization is a shortening of the
refractory period, early research effort was focused on the
potassium currents, which are the major repolarization
currents and are important determinants of action potential
duration (22). However, many reports showed a paradoxical
decrease of potassium channels, either at current density
level or at gene expression level (21). These results excluded
the possibility that an increase of repolarization outward
current shortens the action potential duration. Further
studies have demonstrated that calcium overload with a
decrease of calcium current density might be responsible.
Table 3. The Messenger Ribonucleic Acid Levels of Calcium-
Handling Proteins in Patients With and Without Persistent
Atrial Fibrillation for More than 3 Months
Af <3
Months or
No Af
(n 5 18)
Af >3
Months
(n 5 16)
p
Value
Ca21-ATPase 1.21 6 0.68 0.69 6 0.42 , 0.05
L-type calcium channel 0.90 6 0.88 0.36 6 0.26 , 0.05
Ryanodine receptor 2.01 6 1.17 1.96 6 0.90 NS
Phospholamban 3.78 6 3.36 4.25 6 3.28 NS
Calsequestrin 2.66 6 1.50 2.56 6 1.60 NS
Af 5 atrial fibrillation; Ca21-ATPase 5 calcium adenosine triphosphatase.
Figure 2. The messenger ribonucleic acid (mRNA) levels of
L-type calcium channel and of calcium adenosine triphosphatase
(Ca21-ATPase) in patients with different atrial fibrillation (Af)
scores. The mRNA levels of both genes were significantly de-
creased in patients with an atrial fibrillation score of 3. However,
the mRNA levels were not significantly different among patients
with atrial fibrillation scores of 0, 1 and 2. *p , 0.05 when
compared with atrial fibrillation score 0, 1 and 2. Error bars
represent standard deviations.
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The accumulation of intracellular calcium may be a direct
consequence of rapid atrial depolarization. Rapid depolar-
ization results in cytosolic calcium overload since cells spend
more time in the systolic phase and facilitate the influx of
calcium through L-type calcium channels and further
calcium-induced calcium release from the sarcoplasmic
reticular store. With the use of L-type calcium channel
blocker, the shortening of the refractory period can be
prevented acutely. Wijffels et al. (10) have also reported that
electrical remodeling in atrial fibrillation is not mediated by
changes in autonomic tone, ischemia and atrial stretch.
Therefore, calcium overload plays a pivotal role in the atrial
electrical remodeling, and an understanding of the changes
of calcium-handling proteins is important for the preven-
tion or reversal of the atrial remodeling process.
Time course of changes of calcium-handling proteins in
atrial fibrillation. With regard to the time course of atrial
electrical remodeling, the shortening of the atrial refractory
period happens after a short period of atrial rapid depolar-
ization. Daoud et al. have demonstrated that several minutes
of atrial fibrillation is sufficient to shorten the atrial refrac-
tory period in humans (6). The time course is much shorter
than the time needed for down-regulation of Ca21-ATPase
and L-type calcium channel, which is not evident in patients
with atrial fibrillation for less than three months. Since
intracellular calcium overload is a direct consequence of
rapid atrial depolarization, the increase of cytosolic calcium
will cause a decrease of ICa due to a decrease of electrico-
chemical gradient and an acceleration of ICa inactivation,
which then result in a rapid shortening of action potential
duration (23). Therefore, the decrease of ICa may occur
before the down-regulation of L-type calcium channel.
Besides, the activation of Ca21-activated potassium out-
ward current as well as Ca21-activated chloride outward
current may also contribute to the shortening of action
potential duration (24). However, in the late phase of atrial
fibrillation, the decrease of L-type calcium channel will
further contribute to the shortening of the action potential
duration, and the decrease of the calcium uptake Ca21-
ATPase will further contribute to the cytosolic calcium
overload and enhancement of Ca21-activated potassium
and chloride currents. These changes will aggravate the
shortening of the atrial refractory period or delay the
recovery from remodeling after a long period of atrial
fibrillation. It has been reported clinically that a longer
duration of persistent atrial fibrillation predicts atrial fibril-
lation recurrence after a successful cardioversion (25). This
may be caused by the down-regulation of L-type calcium
channel and Ca21-ATPase after a long duration of atrial
fibrillation and may aggravate the atrial remodeling. Tiele-
man et al. also reported the association between atrial
electrical remodeling and early recurrence of atrial fibrilla-
tion after electrical cardioversion (26). Therefore, the down-
regulation of L-type calcium channel and Ca21-ATPase,
though occurring late in the course, still contributes signif-
icantly to the perpetuation of atrial fibrillation.
Atrial mechanical stretch and atrial electrical remodel-
ing. It has been reported that atrial mechanical stretch may
contribute to the change of electrical properties (27,28). The
perpetuation of atrial fibrillation may also be attributed to
the progression of underlying disease, worsening of the
hemodynamic status and atrial stretch. Therefore we ana-
lyzed the correlation between the atrial filling pressure and
the mRNA levels of calcium-handling proteins. The atrial
filling pressure was represented by the pulmonary wedge
pressure (for the left atrium) and the right atrial pressure
(for the right atrium), which were available in 88% of the
study patients. We demonstrated that the gene expression
changes of L-type calcium channel and Ca21-ATPase were
not related to these hemodynamic parameters. Therefore,
these gene expression changes were a result of atrial fibril-
lation itself instead of being mediated by the hemodynamic
deterioration caused by atrial fibrillation.
Dispersion of gene expression in atrial tissue. Dispersion
of the atrial electrical properties may result in uneven
conduction and repolarization, and therefore contributes to
the occurrence and maintenance of atrial fibrillation. In the
present study, dispersion of gene expression was assessed by
obtaining atrial tissue from four different sites including the
left atrial appendage, the left atrial free wall, the right atrial
appendage and the right atrial free wall, respectively. We
showed that the mRNA levels were not significantly differ-
ent among these atrial sampling sites.
Study limitations. The changes of calcium-handling pro-
teins were assessed at the mRNA level only. There was no
Table 4. The p Values of Correlation Between Messenger Ribonucleic Acid Levels of Calcium-Handling Genes and
Clinical Parameters
Gender Age Af Site RAP PWP Dz CCB
Ca21-ATPase 0.088 0.716 0.001* 0.410 0.630 0.164 0.264 0.182
L-type calcium channel 0.207 0.706 0.006* 0.271 0.847 0.265 0.550 0.256
Ryanodine receptor 0.606 0.746 0.167 0.487 0.223 0.985 0.086 0.502
Calsequestrin 0.277 0.840 0.365 0.613 0.912 0.308 0.520 0.843
Phospholamban 0.484 0.609 0.128 0.358 0.057 0.109 0.091 0.467
*p , 0.05.
Af 5 atrial fibrillation score; Ca21-ATPase 5 calcium adenosine triphosphatase; CCB 5 use of calcium channel blockers; Dz 5 underlying cardiac disease; PWP 5
pulmonary wedge pressure; RAP 5 right atrial pressure.
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investigation about the changes at protein level or at ion
current level. Since the amount of human atrial tissue
obtained was small, especially for the left atrium, we chose
to study the mRNA levels by reverse transcription and
polymerase chain reaction. Although a change of gene
expression is a very common way for regulating functional
protein level, a parallel change between the mRNA level and
the protein level was not demonstrated in the present study.
Patients with different atrial fibrillation scores were not
matched for their age, gender and underlying disease.
Besides, the number of patients in each atrial fibrillation
score group was small. However, we analyzed the effects of
all clinical parameters and showed that atrial fibrillation is
the only factor correlated with a decrease of L-type calcium
channel and of Ca21-ATPase mRNA.
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